Normally, insulin supports lymphangiogenesis and LEC proliferation via PI3K/AKT and extracellular signal-regulated kinase (ERK) pathways.30,31 However, in insulin resistance, dysregulated insulin signaling impairs these processes, reducing lymphangiogenesis, lymphatic drainage, and increasing inflammation in lymphatic vessels. The gene discussed is AKT1; the disease is Insulin resistance.